PRESS RELEASE published on 02/15/2023 at 07:30, 1 year 9 months ago DIC Asset AG: record result in 2022
PRESS RELEASE published on 02/08/2023 at 07:30, 1 year 9 months ago DIC Asset AG lets another 4,140 sqm at Global Tower landmark building in Frankfurt, raising pre-let ratio to 76%
PRESS RELEASE published on 01/25/2023 at 19:44, 1 year 9 months ago DIC Asset AG – the best FFO result in 25 years
PRESS RELEASE published on 01/25/2023 at 19:42, 1 year 9 months ago EQS-Adhoc: DIC Asset AG expects funds from operations of EUR 90 to 97 million for 2023 – Management Board decides on dividend proposal in the amount of EUR 0.75 per share
PRESS RELEASE published on 01/04/2023 at 07:30, 1 year 10 months ago DIC Asset AG disposes of “Kaufhof Chemnitz” asset and achieves its transaction targets for the 2022 financial year
Published on 11/21/2024 at 13:30, 13 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 13 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 43 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 43 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 43 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 8 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 28 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 45 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 23 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
